{"database": "openregs", "table": "documents", "rows": [["EPA-HQ-RCRA-2007-0932-0159", "EPA", "EPA-HQ-RCRA-2007-0932", "Healthcare Distribution Management Association's Response to EPA's Questions About Reverse Distribution of Pharmaceuticals", "Supporting & Related Material", "Letter", "2015-09-25T04:00:00Z", 2015, 9, null, null, "2015-09-25T15:48:15Z", null, 0, 0, "0900006481c0214d"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["EPA-HQ-RCRA-2007-0932-0159"], "units": {}, "query_ms": 75.91358094941825, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}